Triple
T5872822
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | European Union pharmaceutical legislation |
E130557
|
entity |
| Predicate | includes |
P1393
|
FINISHED |
| Object |
Regulation (EC) No 1394/2007
Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
|
E559101
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 1394/2007 | Statement: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Regulation (EC) No 1394/2007 Context triple: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
-
A.
Regulation (EC) No 294/2008
Regulation (EC) No 294/2008 is the EU legislative act that established the European Institute of Innovation and Technology and set out its mission, structure, and operating framework.
-
B.
Regulation (EC) No 726/2004
Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
-
C.
Regulation (EC) No 851/2004
Regulation (EC) No 851/2004 is the EU law that established the European Centre for Disease Prevention and Control and defined its mandate, structure, and functions in coordinating infectious disease surveillance and control across member states.
-
D.
Regulation (EU) No 1094/2010
Regulation (EU) No 1094/2010 is an EU legislative act that established the European Insurance and Occupational Pensions Authority (EIOPA) and set out its powers and supervisory framework for insurance and pension markets in the European Union.
-
E.
Regulation (EU) No 1093/2010
Regulation (EU) No 1093/2010 is the EU legislative act that established the European Banking Authority and set out its mandate, powers, and governance framework for overseeing the banking sector.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Regulation (EC) No 1394/2007 Triple: [European Union pharmaceutical legislation, includes, Regulation (EC) No 1394/2007]
Generated description
Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Regulation (EC) No 1394/2007 Target entity description: Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
-
A.
Regulation (EC) No 294/2008
Regulation (EC) No 294/2008 is the EU legislative act that established the European Institute of Innovation and Technology and set out its mission, structure, and operating framework.
-
B.
Regulation (EC) No 726/2004
Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
-
C.
Regulation (EC) No 851/2004
Regulation (EC) No 851/2004 is the EU law that established the European Centre for Disease Prevention and Control and defined its mandate, structure, and functions in coordinating infectious disease surveillance and control across member states.
-
D.
Regulation (EU) No 1094/2010
Regulation (EU) No 1094/2010 is an EU legislative act that established the European Insurance and Occupational Pensions Authority (EIOPA) and set out its powers and supervisory framework for insurance and pension markets in the European Union.
-
E.
Regulation (EU) No 1093/2010
Regulation (EU) No 1093/2010 is the EU legislative act that established the European Banking Authority and set out its mandate, powers, and governance framework for overseeing the banking sector.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085047dc8190af24e311edad3c07 |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c035f99b788190b5b06d83b9499bfa |
completed | March 22, 2026, 6:33 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0e377e1108190b0820f92eab012c2 |
completed | March 23, 2026, 6:53 a.m. |
| NEDg | Description generation | batch_69c0f72625888190ad23927d0962097b |
completed | March 23, 2026, 8:17 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c0f7fb0cac8190b3b0913689c95542 |
completed | March 23, 2026, 8:21 a.m. |
Created at: March 22, 2026, 3:56 p.m.